Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: UBS Raises Whitbread To Buy From Neutral

Tue, 15th Oct 2019 09:29

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

----------

FTSE 100

----------

UBS RAISES WHITBREAD TO 'BUY' ('NEUTRAL') - PRICE TARGET 4850 PENCE

----------

DEUTSCHE BANK CUTS MONDI PRICE TARGET TO 1950 (2000) PENCE - 'BUY'

----------

JEFFERIES RAISES ASTRAZENECA PRICE TARGET TO 6700 (6550) PENCE - 'HOLD'

----------

CREDIT SUISSE CUTS UNILEVER PRICE TARGET TO 5200 (5210) PENCE - 'OUTPERFORM'

----------

HSBC CUTS RIO TINTO PRICE TARGET TO 4750 (4850) PENCE - 'BUY'

----------

HSBC CUTS GLENCORE PRICE TARGET TO 285 (295) PENCE - 'BUY'

----------

HSBC CUTS BHP GROUP PRICE TARGET TO 1820 (1860) PENCE - 'HOLD'

----------

HSBC RAISES ANGLO AMERICAN PRICE TARGET TO 2400 (2350) PENCE - 'BUY'

----------

JPMORGAN CUTS HARGREAVES LANSDOWN TARGET TO 1610 (1630) PENCE - 'UNDERWEIGHT'

----------

FTSE 250

----------

UBS CUTS SSP GROUP PRICE TARGET TO 695 (715) PENCE - 'NEUTRAL'

----------

DEUTSCHE BANK RAISES EASYJET PRICE TARGET TO 1150 (1100) PENCE - 'HOLD'

----------

BERENBERG CUTS SIG PRICE TARGET TO 100 (135) PENCE - 'HOLD'

----------

RBC RAISES DUNELM GROUP TO 'SECTOR PERFORM' ('UNDERPERFORM') - TARGET 850 PENCE

----------

PEEL HUNT RAISES HILTON FOOD TO 'BUY' ('HOLD')

----------

RBC RAISES ONESAVINGS BANK PRICE TARGET TO 480 (460) PENCE - 'OUTPERFORM'

----------

HSBC CUTS FERREXPO PRICE TARGET TO 215 (310) PENCE - 'BUY'

----------

HSBC RAISES SOPHOS PRICE TARGET TO 583 (435) PENCE - 'HOLD'

----------

JEFFERIES CUTS SOPHOS TO 'HOLD' ('BUY') - TARGET 583 (540) PENCE

----------

JPMORGAN CUTS MAN GROUP PRICE TARGET TO 180 (185) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS JUPITER FUND MANAGEMENT PRICE TARGET TO 345 (360) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS RESTAURANT GROUP PRICE TARGET TO 170 (180) PENCE - 'OVERWEIGHT'

----------

PEEL HUNT CUTS SENIOR PRICE TARGET TO 215 (230) PENCE

----------

OTHER MAIN MARKET AND AIM

----------

HSBC CUTS SOUTH32 PRICE TARGET TO 140 (170) PENCE - 'HOLD'

----------

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
8 Feb 2024 12:08

LONDON MARKET MIDDAY: DS Smith surges on takeover approach from Mondi

(Alliance News) - Stock prices in London were mixed at midday Thursday, as markets struggled to find direction amid a mixed wave of corporate updates and earnings.

Read more
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.